Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
US may be ending grants for biotechs with foreign investors
HHS is allegedly canceling clinical trial funding for biotechs with ties to certain foreign investors, Fierce Biotech has learned.
Gabrielle Masson
Jun 18, 2025 11:50am
Syncona cites 'challenging' market for switching investment plan
Jun 20, 2025 6:00am
Sponsored
Unlocking the power of biospecimens
Jun 16, 2025 8:00am
4 strange cash-saving efforts biotechs are using to stay afloat
Jun 20, 2025 6:00am
Arialys presents promising data for IgG1 antibody treatment
Jun 20, 2025 5:02am
Prothena lays off 63% in fallout from phase 3 amyloidosis fail
Jun 20, 2025 2:23am
More News
Industry disappointed as FDA puts gene therapy chief on leave
Jun 20, 2025 1:53am
Zealand's dual agonist tied to 11% weight loss in phase 1b
Jun 18, 2025 3:00pm
Fierce Biotech Layoff Tracker 2025: BioNTech, Gilead & more
Jun 18, 2025 12:43pm
Fierce Pharma
Bavarian Nordic's $160M PRV price reflects new realities
Jun 18, 2025 11:47am